Drug Shortage Report for LUPRON DEPOT

Last updated on 2020-11-24 History
Report ID 119293
Drug Identification Number 02239833
Brand name LUPRON DEPOT
Common or Proper name Lupron depot 30 mg
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) LEUPROLIDE ACETATE
Strength(s) 30MG
Dosage form(s) POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 syringe
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-09-28
Actual start date 2020-09-09
Estimated end date 2021-01-29
Actual end date
Shortage status Actual shortage
Updated date 2020-11-24
Company comments We have been working with the manufacturing facility to increase production of LUPRON DEPOT and we will continue to distribute supplies as they become available. As production of LUPRON DEPOT continues to increase, we expect inventory of all formulations to stabilize shortly. AbbVie wishes to assure you that we are your primary source of accurate and timely information related to our inventory shortage. The shortage is temporary, and the safety and efficacy of LUPRON DEPOT were not compromised.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-11-24 English Compare
v12 2020-11-24 French Compare
v11 2020-11-24 English Compare
v10 2020-11-24 English Compare
v9 2020-11-24 English Compare
v8 2020-09-10 English Compare
v7 2020-09-08 French Compare
v6 2020-09-08 English Compare
v5 2020-07-08 French Compare
v4 2020-07-08 English Compare
v3 2020-07-07 English Compare
v2 2020-07-02 English Compare
v1 2020-07-02 English Compare